Key result
Among patients with central nervous system lymphoma, the incidence of venous thromboembolism was 59.5%, with most events occurring during the early period of intensive therapy.
Why the study?
What is the incidence of venous thromboembolism in patients with central nervous system lymphoma?
Cohort (n=42)
No
What is the incidence of venous thromboembolism in patients with central nervous system lymphoma?
Patients with CNS lymphoma have a very high incidence of VTE (59.5%), suggesting a potential role for routine anticoagulant prophylaxis during early intensive therapy.
Answers are grounded in this paper and cite their sources.
High VTE incidence in CNS lymphoma may support prophylaxis evaluation; leaves open efficacy confirmation in randomized trials.
BACKGROUND: Venous thromboembolism (VTE) is a frequent complication in patients with cancer throughout the course of the disease. Patients with brain tumors are at particularly high risk for VTE, and several risk factors were found in patients with malignant glioma. To the authors' knowledge, the incidence of VTE in patients with central nervous system (CNS) lymphoma is not known, and possible risk factors have not been identified to date. The objective of this study was to evaluate the frequency and risk factors of VTE in patients with CNS lymphoma. METHODS: The authors retrospectively evaluated the medical records of 42 patients with CNS lymphoma who were treated at their center between 1992 and 2001. RESULTS: It was found that 25 patients (59.5%) had VTE, and, in 3 patients (7%), the VTE was fatal. The authors could not demonstrate that age or ambulatory status could predict VTE in this group of patients, but almost all VTE events occurred during the early period of intensive therapy. CONCLUSIONS: The high incidence of VTE found in this study indicates that anticoagulant prophylaxis with low-molecular-weight heparin probably outweighs the risk and cost of such therapy. A prospective evaluation of newly diagnosed patients with CNS lymphoma is underway at the authors' center.
No takes yet. Share an insight, caveat, or question.
Goldschmidt et al. (2003) conducted a cohort in Central nervous system (CNS) lymphoma (n=42). Central nervous system lymphoma was evaluated on Venous thromboembolism (VTE). Among patients with central nervous system lymphoma, the incidence of venous thromboembolism was 59.5%, with most events occurring during the early period of intensive therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: